vamin 18 electrolyte free 1000ml injection bottle
fresenius kabi australia pty ltd - tryptophan, quantity: 1.9 g/l; arginine, quantity: 11.3 g/l; phenylalanine, quantity: 7.9 g/l; cysteine, quantity: 0.56 g/l; tyrosine, quantity: 0.23 g/l; glycine, quantity: 7.9 g/l; threonine, quantity: 5.6 g/l; methionine, quantity: 5.6 g/l; leucine, quantity: 7.9 g/l; alanine, quantity: 16 g/l; isoleucine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g/l); serine, quantity: 4.5 g/l; histidine, quantity: 6.8 g/l; proline, quantity: 6.8 - injection, intravenous infusion - excipient ingredients: glacial acetic acid; water for injections - intravenous supply of amino acids specially to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is a need to control the total amount of fluid being given to a patient.
vamin 14 electrolyte free 1000ml injection bottle
fresenius kabi australia pty ltd - cysteine, quantity: 0.42 g/l; leucine, quantity: 5.9 g/l; tryptophan, quantity: 1.4 g/l; isoleucine, quantity: 4.2 g/l; alanine, quantity: 12 g/l; tyrosine, quantity: 0.17 g/l; histidine, quantity: 5.1 g/l; serine, quantity: 3.4 g/l; lysine acetate, quantity: 9.5 g/l (equivalent: lysine, qty 6.8 g/l); aspartic acid, quantity: 2.5 g/l; valine, quantity: 5.5 g/l; phenylalanine, quantity: 5.9 g/l; glycine, quantity: 5.9 g/l; methionine, quantity: 4.2 g/l; arginine, quantity: 8.4 g/l; threonine, quantity: 4.2 g - injection, intravenous infusion - excipient ingredients: water for injections; glacial acetic acid - intravenous supply of amino acids to patients with moderately increased requirement who are unable to receive sufficient amounts of protein enterally
synthamin 17 amino acid 10% without electrolytes with glucose 50% 1000ml injection ahb6998
baxter healthcare pty ltd - methionine, quantity: 2 g/l; valine, quantity: 2.9 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); isoleucine, quantity: 3 g/l; glycine, quantity: 5.15 g/l; tryptophan, quantity: 0.9 g/l; histidine, quantity: 2.4 g/l; alanine, quantity: 10.35 g/l; phenylalanine, quantity: 2.8 g/l; tyrosine, quantity: 200 mg/l; glucose, quantity: 250 g/l; threonine, quantity: 2.1 g/l; arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; serine, quantity: 2.5 g/l; proline, quantity: 3.4 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
smofkabiven central emulsion for infusion
fresenius kabi deutschland gmbh - soya bean oil, refined; medium chain triglycerides; refined soyabean oil; fish oil, rich in omega-3 acids; l-alanine; l-arginine; glycine (aminoacetic acid); l-histidine; l-isoleucine; l-leucine; l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; taurine; l-threonine; l-tryptophan; l-tyrosine; l-valine; calcium chloride; sodium glycerophosphate; magnesium sulfate; potassium chloride; sodium acetate; zinc sulfate; glucose - emulsion for infusion - 0 gram(s) - solutions for parenteral nutrition; combinations
vamin 14 electrolyte free 500ml injection bottle
fresenius kabi australia pty ltd - cysteine, quantity: 0.42 g/l; lysine acetate, quantity: 9.5 g/l (equivalent: lysine, qty 6.8 g/l); threonine, quantity: 4.2 g/l; proline, quantity: 5.1 g/l; serine, quantity: 3.4 g/l; glutamic acid, quantity: 4.2 g/l; isoleucine, quantity: 4.2 g/l; arginine, quantity: 8.4 g/l; methionine, quantity: 4.2 g/l; phenylalanine, quantity: 5.9 g/l; glycine, quantity: 5.9 g/l; histidine, quantity: 5.1 g/l; alanine, quantity: 12 g/l; tyrosine, quantity: 0.17 g/l; tryptophan, quantity: 1.4 g/l; aspartic acid, quantity - injection, intravenous infusion - excipient ingredients: water for injections; glacial acetic acid - intravenous supply of amino acids to patients with moderately increased requirement who are unable to receive sufficient amounts of protein enterally
vamin 18 electrolyte free 500ml injection bottle
fresenius kabi australia pty ltd - valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g/l); glutamic acid, quantity: 5.6 g/l; threonine, quantity: 5.6 g/l; glycine, quantity: 7.9 g/l; aspartic acid, quantity: 3.4 g/l; tyrosine, quantity: 0.23 g/l; phenylalanine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; arginine, quantity: 11.3 g/l; alanine, quantity: 16 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; cysteine, quantity: 0.56 g/l; histidine, quantity: 6.8 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; water for injections - intravenous supply of amino acids specially to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is a need to control the total amount of fluid being given to a patient.
smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2531 ml bag
fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated
smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2025 ml bag
fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated
smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1518 ml bag
fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated
smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1012 ml bag
fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated